基于胸部X线片的深度学习预测慢性阻塞性肺疾病患者生存
回顾性收集2011-2015年接受支气管舒张后肺功能检查和胸部X线片的慢阻肺患者数据,开发并验证基于胸片的深度学习生存预测模型(DLSP),并与FEV1及BODE、ADO、CAT、SGRQ等临床指数比较。DLSPCXR在三个外部测试队列中的5年生存预测时间依赖AUC分别为0.73、0.67、0.76,其中两个队列优于FEV1;DLSPinteg与BODE、ADO、SGRQ无显著差异,优于CAT。
要点
- DLSPCXR在三个外部队列的5年生存时间依赖AUC为0.73、0.67、0.76,两队列优于FEV1。
- DLSPinteg与BODE、ADO、SGRQ的AUC无显著差异,但高于CAT。
- DLSPCXR在所有队列中校准良好,Hosmer-Lemeshow检验支持拟合优度。
核心结论
- 使用胸部X线片的深度学习模型能够预测慢性阻塞性肺疾病患者的生存。
研究设计与样本
- 回顾性研究,训练集3475例、验证集435例、内部测试集315例,外部测试三个独立队列分别为394例、416例和337例;参考标准为支气管舒张后肺功能检查和胸部X线片。
诊断标准与关键数值
- DLSPCXR预测5年生存的时间依赖AUC在外部测试队列1为0.73,FEV1为0.63(P = .004)。
- DLSPCXR预测5年生存的时间依赖AUC在外部测试队列2为0.67,FEV1为0.60(P = .01)。
- DLSPCXR预测5年生存的时间依赖AUC在外部测试队列3为0.76,FEV1为0.77(P = .91)。
- DLSPinteg与BODE的TD AUC为0.87 vs 0.80(P = .34),与ADO为0.86 vs 0.89(P = .51),与SGRQ为0.86 vs 0.70(P = .09),与CAT为0.93 vs 0.55(P < .001)。
- DLSPCXR在所有队列中校准良好,采用Hosmer-Lemeshow检验评估拟合优度。
临床应用与阅片要点
- DLSPCXR可利用胸部X线片预测慢阻肺患者5年生存,在部分外部队列中优于FEV1。
- DLSPinteg整合年龄、体重指数和FEV1后,与BODE、ADO、SGRQ的预测性能无显著差异,但高于CAT。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Preexisting indexes for predicting the prognosis of chronic obstructive pulmonary disease (COPD) do not use radiologic information and are impractical because they involve complex history assessments or exercise tests. Purpose To develop and to validate a deep learning-based survival prediction model in patients with COPD (DLSP) using chest radiographs, in addition to other clinical factors. Materials and Methods In this retrospective study, data from patients with COPD who underwent postbronchodilator spirometry and chest radiography from 2011-2015 were collected and split into training (n = 3475), validation (n = 435), and internal test (n = 315) data sets. The algorithm for predicting survival from chest radiographs was trained (hereafter, DLSPCXR), and then age, body mass index, and forced expiratory volume in 1 second (FEV1) were integrated within the model (hereafter, DLSPinteg). For external test, three independent cohorts were collected (n = 394, 416, and 337). The discrimination performance of DLSPCXR was evaluated by using time-dependent area under the receiver operating characteristic curves (TD AUCs) at 5-year survival. Goodness of fit was assessed by using the Hosmer-Lemeshow test. Using one external test data set, DLSPinteg was compared with four COPD-specific clinical indexes: BODE, ADO, COPD Assessment Test (CAT), and St George's Respiratory Questionnaire (SGRQ). Results DLSPCXR had a higher performance at predicting 5-year survival than FEV1 in two of the three external test cohorts (TD AUC: 0.73 vs 0.63 [P = .004]; 0.67 vs 0.60 [P = .01]; 0.76 vs 0.77 [P = .91]). DLSPCXR demonstrated good calibration in all cohorts. The DLSPinteg model showed no differences in TD AUC compared with BODE (0.87 vs 0.80; P = .34), ADO (0.86 vs 0.89; P = .51), and SGRQ (0.86 vs 0.70; P = .09), and showed higher TD AUC than CAT (0.93 vs 0.55; P < .001). Conclusion A deep learning model using chest radiographs was capable of predicting survival in patients with chronic obstructive pulmonary disease. © RSNA, 2022 Online supplemental material is available for this article.
引用
- Nam, Kang, Lee, et al. Deep Learning Prediction of Survival in Patients with Chronic Obstructive Pulmonary Disease Using Chest Radiographs. Radiology. 2022. PMID: 35670713. doi:10.1148/radiol.212071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。